4//SEC Filing
Provost Miriam 4
Accession 0000950170-23-070835
CIK 0001756262other
Filed
Dec 14, 7:00 PM ET
Accepted
Dec 15, 5:31 PM ET
Size
20.1 KB
Accession
0000950170-23-070835
Insider Transaction Report
Form 4
Provost Miriam
VP of US Regulatory & FDA Rel.
Transactions
- Gift
Common Stock
2023-12-15−1,785→ 23,348 total - Exercise/Conversion
Stock Option (Right to Buy)
2023-12-13−1,632→ 7,073 totalExercise: $66.10Exp: 2033-02-20→ Common Stock (1,632 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2023-12-13−3,597→ 7,813 totalExercise: $38.46Exp: 2031-02-24→ Common Stock (3,597 underlying) - Exercise/Conversion
Common Stock
2023-12-13$16.14/sh+415$6,698→ 24,026 total - Sale
Common Stock
2023-12-13$75.10/sh−206$15,471→ 23,820 total - Exercise/Conversion
Common Stock
2023-12-13$66.10/sh+1,632$107,875→ 25,452 total - Sale
Common Stock
2023-12-13$75.10/sh−1,509$113,326→ 23,943 total - Exercise/Conversion
Common Stock
2023-12-13$38.46/sh+3,597$138,341→ 27,540 total - Sale
Common Stock
2023-12-13$75.10/sh−2,407$180,766→ 25,133 total - Exercise/Conversion
Stock Option (Right to Buy)
2023-12-13−415→ 7,811 totalExercise: $16.14Exp: 2030-02-27→ Common Stock (415 underlying)
Footnotes (6)
- [F1]The exercise followed the sell-to-cover process, whereby a portion of the shares acquired through the exercise were sold in the open market, with the proceeds used to fund the aggregate exercise price of the options.
- [F2]On December 15, 2023, the reporting person donated 1,785 shares of directly owned common stock to a donor-advised fund, which will use the gifted shares for charitable purposes.
- [F3]Includes 5,685 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.
- [F4]The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 27, 2020.
- [F5]The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 20, 2023.
- [F6]The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 24, 2021.
Documents
Issuer
TransMedics Group, Inc.
CIK 0001756262
Entity typeother
Related Parties
1- filerCIK 0001773663
Filing Metadata
- Form type
- 4
- Filed
- Dec 14, 7:00 PM ET
- Accepted
- Dec 15, 5:31 PM ET
- Size
- 20.1 KB